The Checklist for Early Recognition and Treatment of Acute Illness (CERTAIN)

The purpose of the study is to test whether the health care provider access and training in CERTAIN (Checklist for Early Recognition and Treatment of Acute Illness), would facilitate timely and error free best-practice delivery and minimize preventable death and costly complications in critically ill patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Critical Illness Bleeding Coma Consciousness Disorders Disease Attributes Hemorrhage Infections Inflammation Nervous System Diseases Neurobehavioral Manifestations Neurologic Manifestations Pathologic Processes Pathological Conditions, Signs and Symptoms Respiration Disorders Respiratory Failure Respiratory Insufficiency Respiratory Tract Diseases Sepsis Shock Signs and Symptoms Systemic Inflammatory Response Syndrome Trauma Unconsciousness Wounds and Injuries

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Gomel Regional Clinical Hospital, Homyel, Belarus

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion:

All adult (≥ 18 years) patients admitted for the first time to the participating ICUs will be included.

Exclusion:

Not critically Ill, admitted for low risk monitoring, planned ICU admissions for routine postoperative surveillance for less than 24 hours after uncomplicated surgery, readmission and transferred from outside ICU.

Treatment and study plan

Checklist for Early Recognition and Treatment of Acute Illness (CERTAIN)

Other

This study is about training and implementation of best critical care practices in the international ICUs with variable resources facilitated by access to a specifically designed electronic checklist

Other names: Checklist

Primary outcomes

Adherence to best critical care practices

Time frame: Participants will be followed for the duration of ICU stay, an expected average of 2 weeks

Adherence to best practice in initial evaluation and treatment of critically ill medical and surgical patients Appropriate shock resuscitation Appropriate sepsis treatment Appropriate mechanical ventilation Appropriate peptic ulcer, deep vein thrombosis and infectious disease prophylaxis
ICU and hospital lengths of stay

Time frame: Participants will be followed for the duration of hospital stay, an expected average of 8 weeks

Patient will be followed till they get discharged from hospital for whatever length they stay.

Secondary outcomes

Mortality for 4 weeks

Time frame: Participants will be followed for the duration of 4 weeks and hospital discharge (up to 10 weeks post discharge)

Patient will be followed for 4 weeks and hospital discharge(up to total 10 weeks post discharge)

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Registry information

Important dates

Study start: 2013
Primary completion: 2017
Study completion: 2018
First posted: Nov 1, 2013
Registry last updated: Aug 20, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed